Skip to content
Sorrento Therapeutics, Inc.
$25,000,000
Public Offering
Common Stock
May 2014
Read More
Cyclacel Pharmaceuticals Inc.
$10,000,000
Secondary Public Offering
Represented Underwriter
Common Stock
April 2014
Read More
NovaBay Pharmaceuticals, Inc.
$6,720,000
Secondary Public Offering
Common Stock & Warrants
March 2014
Read More
Relmada Therapeutics Inc.
$10,000,000
PIPE
Common Stock & Warrants
May 2014
Read More
AV Therapeutics
$1,260,000
PIPE
Common Stock & Warrants
April 2014
Read More
UX2 Biosystems, Inc.
$2,500,000
PIPE
Promissory Notes & Common Stock Purchase Warrants
April 2014
Read More
ClearSign
$6,500,000
Registered Direct Offering
Represented Placement Agent
March 2014
Read More
Cell Source
$3,600,000
Common Stock, Warrants
February 2014
Read More
SMTP, Inc.
$10,000,000
Public Offering – Representing Aegis Capital Corp.
February 2014
Read More
Be Active Holdings
$1,799,999
Common Stock, Warrants Included
February 2014
Read More